Tenapanor Alternatives Compared
| Tenapanor | Linzess (linaclotide) | Zelnorm (tegaserod) |
|
|---|
| Tenapanor | Linzess (linaclotide) | Zelnorm (tegaserod) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Irritable Bowel Syndrome with Constipation, Hyperphosphatemia of Renal Failure. Tenapanor may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Chronic Idiopathic Constipation, Irritable Bowel Syndrome with Constipation, Functional Constipation, Irritable Bowel Syndrome. Linzess may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Irritable Bowel Syndrome with Constipation. Zelnorm may also be used for purposes not listed in this medication guide. |
Related suggestions Irritable Bowel Syndrome with Constipation
|
|||||||
| More about Tenapanor | More about Linzess (linaclotide) | More about Zelnorm | ||||||||
| Ratings & Reviews | ||||||||||
|
Tenapanor has an average rating of 8.9 out of 10 from a total of 21 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 0% reported a negative effect. |
Linzess has an average rating of 6.7 out of 10 from a total of 885 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 26% reported a negative effect. |
Zelnorm has an average rating of 8.8 out of 10 from a total of 44 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Tenapanor side effects |
View all Linzess side effects |
View all Zelnorm side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Linzess prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
|
||||||||
| Brand Names | ||||||||||
| Ibsrela, Xphozah |
N/A |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
N/A |
N/A |
16 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 59 drugs are known to interact with Linzess:
|
A total of 2 drugs are known to interact with Zelnorm:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
September 12, 2019 |
August 30, 2012 |
July 24, 2002 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.